Falagario, U.G.; Sanguedolce, F.; Cormio, A.; Ninivaggi, A.; Finati, M.; Guzzi, F.; Busetto, G.M.; Bettocchi, C.; Castellani, D.; Carrieri, G.;
et al. The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy. Diagnostics 2025, 15, 166.
https://doi.org/10.3390/diagnostics15020166
AMA Style
Falagario UG, Sanguedolce F, Cormio A, Ninivaggi A, Finati M, Guzzi F, Busetto GM, Bettocchi C, Castellani D, Carrieri G,
et al. The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy. Diagnostics. 2025; 15(2):166.
https://doi.org/10.3390/diagnostics15020166
Chicago/Turabian Style
Falagario, Ugo Giovanni, Francesca Sanguedolce, Angelo Cormio, Antonella Ninivaggi, Marco Finati, Francesco Guzzi, Gian Maria Busetto, Carlo Bettocchi, Daniele Castellani, Giuseppe Carrieri,
and et al. 2025. "The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy" Diagnostics 15, no. 2: 166.
https://doi.org/10.3390/diagnostics15020166
APA Style
Falagario, U. G., Sanguedolce, F., Cormio, A., Ninivaggi, A., Finati, M., Guzzi, F., Busetto, G. M., Bettocchi, C., Castellani, D., Carrieri, G., & Cormio, L.
(2025). The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy. Diagnostics, 15(2), 166.
https://doi.org/10.3390/diagnostics15020166
